Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Pfizer Inc. | 30 | 4 | 3 | 0 | €26.36 | €40.66 | 54.276% |
| PTC Therapeutics Inc. | 15 | 9 | 1 | 2 | €33.20 | €41.51 | 25.038% |
| Agios Pharmaceuticals Inc. | 8 | 0 | 2 | 0 | €42.40 | €43.87 | 3.465% |
| AnaptysBio Inc | 8 | 1 | 0 | 0 | €22.40 | €45.21 | 101.830% |
| Rhythm Pharmaceuticals | 15 | 0 | 0 | 0 | €39.20 | €46.08 | 17.557% |
| Pacira Pharmaceuticals | 18 | 0 | 0 | 0 | €26.80 | €47.53 | 77.343% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €42.80 | €50.00 | 16.822% |
| Halozyme Therapeutics Inc. | 20 | 0 | 5 | 0 | €48.74 | €52.75 | 8.223% |
| Arrowhead Pharmaceuticals Inc. | 18 | 2 | 4 | 0 | €25.44 | €54.74 | 115.189% |
| Ionis Pharmaceuticals Inc. | 20 | 5 | 1 | 0 | €42.05 | €56.72 | 34.891% |
| Celldex Therapeutics | 15 | 1 | 4 | 0 | €33.80 | €58.01 | 71.629% |
| Intellia Therapeutics Inc | 17 | 1 | 4 | 0 | €22.97 | €60.53 | 163.537% |
| Insmed Inc. | 33 | 0 | 15 | 0 | €64.00 | €65.83 | 2.859% |
| Incyte Corp. | 12 | 2 | 0 | 0 | €59.34 | €78.05 | 31.525% |
| Gilead Sciences Inc | 13 | 1 | 2 | 0 | €66.00 | €83.21 | 26.068% |
| Cytokinetics Inc. | 34 | 1 | 4 | 0 | €48.40 | €83.21 | 71.911% |
| Intra-Cellular Therapies Inc. | 31 | 0 | 6 | 0 | €68.50 | €83.92 | 22.512% |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 6 | 0 | €36.80 | €85.51 | 132.368% |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €74.20 | €100.00 | 34.771% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 0 | 0 | €78.30 | €102.62 | 31.059% |
| Abbott Laboratories | 18 | 0 | 1 | 0 | €98.43 | €116.48 | 18.338% |
| Merck & Co. Inc. | 32 | 1 | 4 | 0 | €124.60 | €125.34 | 0.592% |